papaverine has been researched along with Body Weight in 19 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the role played by angiotensin II (AII) in the development of prehypertensive vascular hypertrophy in the spontaneously hypertensive rat (SHR) and to determine whether normalization of prehypertensive vascular hypertrophy attenuates the development of hypertension." | 3.69 | Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats. ( Black, MJ; Bobik, A; Kanellakis, P, 1997) |
| " We found a shift in the dose-response curve of only phosphodiesterase 5 inhibitors." | 1.32 | The effect of chronic renal failure on phosphodiesterase inhibitor-induced relaxation responses in rabbit cavernosal strips. ( Bagcivan, I; Gokce, G; Kilicarslan, H; Sarac, B; Sarioglu, Y; Yildirim, S, 2003) |
| "Treatment with melatonin (EC(50) 4." | 1.32 | Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. ( Ayanğolu-Dülger, G; Paskaloglu, K; Sener, G, 2004) |
| "Allometric scaling is an empirical examination of the relationships between the pharmacokinetic parameters and size (usually body weight, ratio of organ- and body weight, breathing number, etc." | 1.30 | [Interspecies allometric scaling in pharmacokinetics of drugs]. ( Sylvia, M, 1998) |
| " The naltrexone stimulus-generalization curve and dose-response curve for loss of body weight were shifted to the left by IBMX and Ro 20-1724, which produce quasi-withdrawal, but not by papaverine, which does not." | 1.28 | Phosphodiesterase inhibitors potentiate opiate-antagonist discrimination by morphine-dependent rats. ( Holtzman, SG, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Adamchuk, D | 1 |
| Kuziev, M | 1 |
| Gurman, E | 1 |
| Niyazmetov, B | 1 |
| Kilicarslan, H | 1 |
| Yildirim, S | 1 |
| Bagcivan, I | 1 |
| Gokce, G | 1 |
| Sarac, B | 1 |
| Sarioglu, Y | 1 |
| Martinez-Lemus, LA | 1 |
| Hester, RK | 1 |
| Becker, EJ | 1 |
| Ramirez, GA | 1 |
| Odom, TW | 1 |
| Tatchum-Talom, R | 1 |
| Martin, DS | 1 |
| Paskaloglu, K | 1 |
| Sener, G | 1 |
| Ayanğolu-Dülger, G | 1 |
| Lai, FM | 1 |
| Tanikella, T | 1 |
| Thibault, L | 1 |
| Chan, PS | 1 |
| Cervoni, P | 1 |
| Sikorski, BW | 1 |
| James, GM | 1 |
| Glance, SD | 1 |
| Hodgson, WC | 1 |
| King, RG | 1 |
| Fuentes, J | 1 |
| Eddy, FB | 1 |
| Black, MJ | 1 |
| Kanellakis, P | 1 |
| Bobik, A | 1 |
| Chew, HG | 1 |
| Segal, SS | 1 |
| Grossman, HJ | 1 |
| Grossman, VL | 1 |
| Bhathal, PS | 1 |
| Priest, RM | 1 |
| Robertson, TP | 1 |
| Leach, RM | 1 |
| Ward, JP | 1 |
| Sylvia, M | 1 |
| Kirby, MJ | 1 |
| Leighton, M | 1 |
| Turner, P | 1 |
| Henrion, D | 1 |
| Chillon, JM | 1 |
| Hoffman, M | 1 |
| Capdeville-Atkinson, C | 1 |
| Atkinson, J | 1 |
| Holtzman, SG | 1 |
| Lemke, H | 1 |
| Oettel, M | 1 |
| Chemnitius, KH | 1 |
| Burberi, S | 1 |
| Silvestrini, B | 1 |
| Dewey, WL | 1 |
| Malone, MH | 1 |
19 other studies available for papaverine and Body Weight
| Article | Year |
|---|---|
INFLUENCE OF PAPAVERINE AND COMMERCIAL DIETARY SUPPLEMENTS ON BLOOD GLUCOSE AND BODY WEIGHT IN OBESE DOGS.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Dietary Supplements; Obesity; Papaverine | 2023 |
The effect of chronic renal failure on phosphodiesterase inhibitor-induced relaxation responses in rabbit cavernosal strips.
Topics: Amrinone; Animals; Body Weight; Calcium; Creatinine; Dose-Response Relationship, Drug; Electric Stim | 2003 |
Pulmonary artery vasoactivity in broiler and Leghorn chickens: an age profile.
Topics: Acetylcholine; Aging; Animals; Body Weight; Chick Embryo; Chickens; Endothelin-1; Organ Size; Papave | 2003 |
Tempol improves vascular function in the mesenteric vascular bed of senescent rats.
Topics: Administration, Oral; Aging; Animals; Blood Pressure; Body Weight; Cyclic N-Oxides; Dose-Response Re | 2004 |
Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental | 2004 |
Effects of different stages of aortic coarctation hypertension on aortic contraction and relaxation in rats.
Topics: Animals; Aorta; Aorta, Abdominal; Aorta, Thoracic; Body Weight; Hypertension; Isoproterenol; Ligatio | 1980 |
Effect of endothelium on diabetes-induced changes in constrictor responses mediated by 5-hydroxytryptamine in rat aorta.
Topics: Amphetamines; Animals; Aorta; Arginine; Body Weight; Diabetes Mellitus, Experimental; Endothelium; I | 1993 |
Effect of manipulation of the renin-angiotensin system in control of drinking in juvenile Atlantic salmon (Salmo salar L) in fresh water and after transfer to sea water.
Topics: Angiotensin II; Animals; Body Weight; Chlorides; Drinking; Fresh Water; Papaverine; Renin-Angiotensi | 1997 |
Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensiv | 1997 |
Arterial morphology and blood volumes of rats following 10-14 weeks of tail suspension.
Topics: Analysis of Variance; Animals; Blood Volume; Body Weight; Female; Femoral Artery; Hindlimb; Hindlimb | 1997 |
The effect of hepatocyte enlargement on the hemodynamic characteristics of the isolated perfused rat liver preparation.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Hypertrophy; Hypotonic Solutions; In Vitro T | 1998 |
Membrane potential-dependent and -independent vasodilation in small pulmonary arteries from chronically hypoxic rats.
Topics: Animals; Body Weight; Cromakalim; Dinoprost; Dose-Response Relationship, Drug; Heart Ventricles; Hem | 1998 |
[Interspecies allometric scaling in pharmacokinetics of drugs].
Topics: Animals; Body Weight; Cats; Dogs; Drug Combinations; Humans; Mice; Organ Size; Papaverine; Parasympa | 1998 |
The influence of premedication, anaesthesia, age and weight on glucose uptake into human isolated skeletal muscle.
Topics: Adult; Age Factors; Aged; Anesthesia; Atropine; Body Weight; Female; Glucose; Glycogen; Humans; Male | 1976 |
Decrease in endothelium-dependent relaxation in the mesenteric arterial bed following vascular calcium overload produced by vitamin D3 and nicotine in rats.
Topics: Animals; Body Weight; Calcium; Carbachol; Cholecalciferol; Endothelium; Histamine; Male; Muscle Rela | 1991 |
Phosphodiesterase inhibitors potentiate opiate-antagonist discrimination by morphine-dependent rats.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Body Weight; D | 1989 |
[Pharmacologic-endocrinological findings in animal experiments with TURISYNCHRON and SUISYNCHROM. 2. Toxicologic findings].
Topics: Acute Disease; Administration, Oral; Animals; Atropine; Body Weight; Chlorpromazine; Chronic Disease | 1974 |
Preventive action of proxazole in experimentally induced renal hypertension in rats.
Topics: Animals; Arteries; Blood Pressure; Body Weight; Ethylamines; Female; Hypertension, Renal; Male; Neph | 1971 |
Pharmacologic and toxicologic evaluation of 2-(N-tetradecyl-N-ethylamino)-2-methyl-1,3-propanediol hydrochloride, an inhibitor of intestinal absorption.
Topics: Animals; Anti-Infective Agents, Local; Appetite Depressants; Basal Metabolism; Biological Transport, | 1968 |